Rachel Humphrey - Researcher Profile

Publications

2 shown

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

Caroline Robert , L. Thomas , Igor Bondarenko +21 more

Ipilimumab (at a dose of 10 mg per kilogram) in combination with dacarbazine, as compared with dacarbazine plus placebo, improved overall survival in patients with previously un...

2011 New England Journal of Medicine 4405 citations

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

Jedd D. Wolchok , Axel Hoos , Steven O’Day +9 more

Abstract Purpose: Immunotherapeutic agents produce antitumor effects by inducing cancer-specific immune responses or by modifying native immune processes. Resulting clinical res...

2009 Clinical Cancer Research 3168 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 7,573
Institution: Bristol-Myers Squibb (United States)

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0009-0007-6425-675X

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.